Dr. Christoph C. Dengler

Practice

Buy-Side & Diligence Support

Sharper diligence and better decisions for PE deal teams, with a former ExCom and General Counsel industry perspective on material risks, value drivers and execution certainty.

Sharper diligence. Better decisions.

Supporting PE deal teams and external counsel with a former ExCom and General Counsel industry perspective focused on material risks, value drivers and execution certainty.

Areas of Support

  • Buy-side legal diligence support
  • DD coordination, issue prioritization and Q&A strategy
  • Expert sessions with management and functional leaders
  • Review of key value drivers and legal downside risks
  • Pharma-specific review of licensing, supply, distribution, sanctions, HCP/HCO and regulatory topics
  • Review of governance, compliance and risk management maturity
  • Distinction between red flags, non-issues and post-closing clean-up items
  • Translation of legal, compliance, and IP findings into IC-relevant input
  • Structuring of post-closing clean-up roadmap for DD findings
  • Early view on exit implications of identified issues

Focus

  • Identifying what truly matters to assess the target.
  • Avoiding legal noise.